Stereotaxis (STXS) Cash & Equivalents (2010 - 2026)

Stereotaxis (STXS) has 17 years of Cash & Equivalents data on file, last reported at $14.6 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 37.87% year-over-year to $14.6 million in Q1 2026; TTM through Mar 2026 was $14.6 million, a 37.87% increase from a year earlier, with the FY2025 full-year figure at $13.4 million, up 9.86% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $14.6 million, up from $13.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for STXS reached as high as $36.9 million in Q1 2022 and fell as low as $6.8 million in Q1 2023.
• Historically, Cash & Equivalents has averaged $18.8 million across 5 years, with a median of $15.2 million in 2024.
• Across the five-year window, Cash & Equivalents slumped 81.66% in 2023 and jumped 169.91% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $29.7 million in 2022, then tumbled by 30.77% to $20.6 million in 2023, then slumped by 40.58% to $12.2 million in 2024, then gained by 9.86% to $13.4 million in 2025, then advanced by 8.9% to $14.6 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $14.6 million in Q1 2026, $13.4 million in Q4 2025, and $10.5 million in Q3 2025.